Abrocitinib API in Pakistan: Raw Material for Pharmaceutical Formulators

Raw Material for Pharmaceutical Formulators

Product Name: Abrocitinib (Active Pharmaceutical Ingredient)

Therapeutic Category: Janus kinase (JAK) inhibitors

Indications: Atopic dermatitis

Important Notice: This page is strictly for pharmaceutical manufacturers, research laboratories, and B2B distributors. Abrocitinib, in this form, is a raw Active Pharmaceutical Ingredient (API) and is not a finished medicine or prescription drug for patient consumption.

About Morgan: Morgan Chemicals (Pvt.) Ltd. is a pharmaceutical raw material trading and distribution company. We source APIs from DRAP-registered and internationally certified manufacturers and supply exclusively to licensed pharmaceutical companies, CMOs, and research facilities. We do not manufacture APIs or sell finished medicines.

Product Overview

If your pharmaceutical facility is developing treatments for severe inflammatory skin conditions, securing a reliable supply of high-purity API is your first hurdle. Abrocitinib is a small-molecule active ingredient classified as a selective Janus kinase 1 (JAK1) inhibitor.

In finished drug formulations, this API is indicated for the treatment of moderate-to-severe atopic dermatitis (eczema) in adults and adolescents. Unlike broad-spectrum immunosuppressants, Abrocitinib works by specifically blocking the JAK1 pathway, which is responsible for signaling the key cytokines (like IL-4, IL-13, and IL-31) that cause the chronic itching and skin inflammation associated with eczema.

For formulation scientists, this means you are working with a targeted, highly effective raw material designed for oral solid dosage forms (typically tablets).

Why Sourcing Abrocitinib in Pakistan Matters

The demand for advanced dermatological therapies is growing, and local manufacturing is stepping up to meet it. However, importing specialty APIs comes with logistical and regulatory hurdles.

When you source Abrocitinib Pakistan through a dedicated local supply network, you bypass many of the common supply chain bottlenecks. We focus on providing pharmaceutical companies in Pakistan with raw materials that meet strict international Pharmacopeial standards, while also ensuring smooth alignment with local requirements.

Key advantages for local manufacturers include:

• DRAP Submission Assistance: Morgan coordinates with DRAP-registered API manufacturers to obtain and forward the necessary documentation, including open parts of the Drug Master File (DMF), to assist your regulatory affairs team with Drug Regulatory Authority of Pakistan (DRAP) submissions and product registration.
• Reduced Lead Times: Avoid the delays of international shipping and customs hold-ups by utilizing our streamlined supply channels.
• Consistent Batch Quality: We understand that QA/QC departments require absolute consistency. Every shipment coordinated by Morgan includes a detailed Certificate of Analysis (CoA) issued by the original manufacturer to ensure your formulation process remains stable from pilot to commercial scale.

Technical Specifications for QA & R&D

For your quality control and formulation teams, the technical integrity of the API is the most critical factor. Our Abrocitinib API is manufactured in GMP-certified facilities to ensure high purity and low residual solvents.

• Chemical Name: N-[cis-3-(Methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclobutyl]propane-1-sulfonamide
• Appearance: White to off-white solid powder
• Molecular Weight: 323.42 g/mol
• Purity (HPLC): ≥ 99.0%
• Moisture Content: ≤ 0.5%
• Solubility: Formulators should note its specific solubility profiles in organic solvents (detailed in the technical data sheet) for wet granulation or direct compression processes.

Manufacturing and Handling Guidelines

Because Abrocitinib is a potent immunomodulator, your manufacturing facility must employ appropriate handling protocols during weighing, milling, and blending.

• Storage Conditions: The API must be stored in a tightly sealed container in a cool, dry place. It should be protected from excessive heat and direct light to maintain chemical stability.
• Worker Safety: Operators handling the raw powder must use adequate Personal Protective Equipment (PPE), including dust masks or respirators, gloves, and protective clothing to prevent accidental inhalation or dermal contact.

Partnering for Your Next Dermatological Formulation

Transitioning a new drug from R&D to commercial production requires a reliable API partner. As your sourcing partner, Morgan connects you with verified, GMP-certified API manufacturers and provides local logistical support, regulatory documentation coordination, and supply chain reliability you need to successfully launch your Abrocitinib-based treatment in the market.